Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023
BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company…
BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company…
REDWOOD CITY, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS),…
Spotlight on Novel, Targeted Technologies to Enhance Engraftment, Expansion and Persistence of AlloCAR T™ Cells…
WALTHAM, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…
TORONTO and ABU DHABI, United Arab Emirates, Sept. 27, 2023 (GLOBE NEWSWIRE) — Basetwo, a…
Funding underscores shift toward open banking and the demand for seamless core integration and innovation…
Experienced Epiq AI and Data Management Technologists Deliver Solutions Leveraging the Epiq Service Cloud NEW YORK,…
Toronto, Ontario–(Newsfile Corp. – September 27, 2023) – Two Hands Corporation. (CSE: TWOH) (“Two Hands”…
Toronto, Ontario–(Newsfile Corp. – September 27, 2023) – Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (formerly…
Toronto, Ontario–(Newsfile Corp. – September 27, 2023) – SATO Technologies Corp. (TSXV: SATO) (OTCQB: CCPUF)…
MUMBAI, INDIA, Sept 27, 2023 – (ACN Newswire) – StrategINK Solutions Private Limited successfully concluded…
SINGAPORE, Sept 27, 2023 – (ACN Newswire) – PT Bank Tabungan Negara (Persero) Tbk (Bank…
Hugging Face, the leader in open source AI, will offer optimized Generative AI models to…
Building the AI railroad tracks of the future so inference tasks can move seamlessly across…
Cloudflare joins MLflow as an active contributor to bridge the gap between model training and…
NEW YORK–(BUSINESS WIRE)–Flatiron Health is presenting multiple sessions at HMP Global’s Clinical Pathways Congress +…
The newly launched customizable Cybersecurity Performance Boards empower security leaders to manage their own metrics…
MANNHEIM, Germany, Sept. 27, 2023 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the…
MANNHEIM, Germany, Sept. 27, 2023 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the…
BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical…